With the launch of the Wegovy pill in the U.S., Novo Nordisk announced this week that it is adding manufacturing capacity to its Athlone, Ireland site to support current and future GLP-1 treatments
At room temperature, any stray microbe finds a much more hospitable environment to multiply
Anything shorter and you're looking at something like a tattoo needle, and that's not an appropriate tool for injecting a medication
PT-141 is designed for convenience and privacy, typically administered as a simple nasal spray or a small, self-administered injection
Navigating GLP-1 Diabetes and Weight Loss Drug Side Effects While GLP-1 receptor agonists have gained popularity for weight loss and diabetes management, their benefits often come at the cost of significant risks and limitations
doi:10.1097/ede.0000000000001247